Sbc Medical Group Holdings Incorporated ( (SBC) ) has released its Q2 earnings. Here is a breakdown of the information Sbc Medical Group Holdings Incorporated presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
SBC Medical Group Holdings Incorporated is a global company that owns, operates, and provides management services and products to cosmetic treatment centers, primarily focusing on franchise clinics. Headquartered in Irvine, California, and Tokyo, Japan, the company offers a wide range of services including advertising, staff management, and medical equipment procurement.
In its second quarter 2025 financial report, SBC Medical Group Holdings reported a significant decline in key financial metrics. Total revenues decreased by 18% year-over-year to $43 million, while net income dropped by 87% to $2.5 million. Earnings per share also saw a sharp decline from $0.20 to $0.02 compared to the same period in 2024.
The company’s EBITDA fell by 46% to $15 million, with an EBITDA margin of 35%, down from 53% in the previous year. Despite these declines, the company expanded its franchise locations to 259 and saw a 14% increase in customer numbers, reaching 6.31 million over the last twelve months.
SBC Medical’s management attributes the revenue decline to strategic shifts, including the discontinuation of its staffing business and targeted divestitures. The company remains focused on optimizing its franchise model and transitioning to higher-margin models to capture growth opportunities and deliver lasting value to shareholders.
Looking forward, SBC Medical is confident in its strategic roadmap, emphasizing its commitment to long-term competitiveness and scalability, despite challenges in Japan’s consumer discretionary market.